Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Hematology · Chronic Myeloid Leukemia

Can Ph-Positive CML Cause Leukostasis Without Symptoms?

At a Glance

In Philadelphia-positive CML, a very high white blood cell count does not always mean leukostasis, and some people feel well. Same-day medical assessment is needed because hidden organ problems can occur; headache, confusion, vision, breathing, chest, or urination changes require emergency care.

Finding out your white blood cell count is extremely high can be terrifying, especially when you are newly diagnosed with chronic myeloid leukemia (CML). It is important to know that a very high count is not always a medical emergency, but it requires immediate, same-day attention from a hematology team [1]. In CML, having a high number of white blood cells on a lab test is known as hyperleukocytosis [2]. This is distinct from leukostasis, a true medical emergency where those excess cells clump together, thickening the blood and physically blocking small blood vessels [1][3]. While many people with CML have high counts without having leukostasis, any newly reported extreme white blood cell count means you must contact your oncology team the same day for a specialized assessment, even if you feel completely well.

The Difference Between a High Count and Leukostasis

Many patients with CML are diagnosed with white blood cell counts well above normal—often over 100,000 cells per microliter [2]. Up to 40% of patients with newly diagnosed CML feel perfectly fine and have no noticeable symptoms at the time [4].

There is no single “danger number” or universal white blood cell cutoff that reliably predicts leukostasis. Instead, your risk depends on several factors:

  • The phase of your CML: Leukostasis is less common in the early “chronic phase” and more concerning if the disease is in an advanced “accelerated” or “blast” phase [5][6].
  • The types of cells: A high proportion of immature leukemia cells (blasts) makes the blood thicker and stickier than mature cells do.
  • Organ function: The difference between a high lab number and a medical emergency is whether your organs are actually being deprived of oxygen [2].

If you have hyperleukocytosis but no signs of organ distress, doctors generally do not aggressively treat the number itself as an emergency [1]. However, leukostasis requires immediate treatment to prevent life-threatening complications like respiratory failure or intracranial hemorrhage (bleeding in the brain) [2][6].

Why “Feeling Fine” Can Be Tricky

Even if you feel well, you need a prompt clinical assessment because some signs of leukostasis are subtle. For instance, blocked vessels in the eyes can cause retinal hemorrhages (bleeding in the back of the eye) that you might not notice immediately, or they might just cause mild blurred vision [7][8]. Similarly, high white counts can sometimes impact your hearing [9], and your blood oxygen might drop only when you exert yourself, like when walking [10].

Because of these hidden signs, your doctor will not rely on your lab numbers alone. They will evaluate your overall physical function, check your blood oxygen and kidney function, and review your blood smear. If your symptoms or exam raise concerns, they may also order specialized tests like a formal eye exam or hearing test [8][9][2].

Emergency Symptoms to Watch For

If you have a significantly elevated white blood cell count, you or your family should call emergency services immediately if you experience any of the following warning signs. Do not drive yourself to the hospital, and tell the paramedics you have CML with hyperleukocytosis.

  • Neurologic: Severe or new headache, confusion, dizziness, vomiting, weakness on one side of the body, or a sudden decline in alertness or consciousness [5][11].
  • Visual or Auditory: Sudden vision loss, marked blurring, or sudden difficulty hearing [8][9].
  • Respiratory and Chest: Shortness of breath, difficulty breathing, or sudden chest pain [12][13].
  • Other critical signs:
    • An erection lasting four hours or longer, or one that is painful (a urologic emergency called priapism) [7][14].
    • Significantly decreased urination, which could indicate acute kidney injury or tumor lysis syndrome [2].
    • Severe, unexplained pain in your calves or legs, which may indicate a blocked vessel in your limb [7].

How Your Care Team Manages a High Count

Your medical team’s approach depends on your CML phase, cell types, and whether you have symptoms of leukostasis.

  • For chronic-phase CML without leukostasis: The priority is usually to start your standard targeted therapy (a tyrosine kinase inhibitor, or TKI) promptly once your diagnosis is confirmed [15][16]. Your team will monitor your blood and may prescribe medications like allopurinol to protect your kidneys from tumor lysis syndrome, which occurs when cancer cells break down quickly [17][2]. They will also give you a specific hydration plan; please follow their instructions rather than forcing fluids on your own, especially if you have heart or kidney conditions.
  • If you have symptoms of leukostasis or advanced phase CML: Your team will act quickly to reduce your white blood cell count and relieve the blockages [5]. They may use an oral chemotherapy drug like hydroxyurea as a temporary bridge to quickly lower the count [15]. In specific, severe cases, a specialist team might perform leukapheresis, a procedure where a machine filters the excess white blood cells directly out of your blood [5][18].

Common questions in this guide

Can I have leukostasis from CML if I do not feel sick?
Yes, it is possible to have subtle or early effects without feeling obviously ill, but a high white blood cell count by itself does not prove leukostasis. Leukostasis means excess leukemia cells are obstructing small blood vessels and affecting organs, so any extreme new count needs same-day assessment by your hematology team.
Does a white blood cell count over 100,000 always mean an emergency?
No. Many people with CML have counts above 100,000 without leukostasis, and there is no single cutoff that reliably predicts it. Doctors also consider the CML phase, the number of immature cells, symptoms, and organ function.
What symptoms mean I should call emergency services?
Call emergency services for a new severe headache, confusion, unusual sleepiness, one-sided weakness, sudden vision or hearing changes, trouble breathing, or chest pain. Markedly reduced urination, severe calf or leg pain, or a painful or prolonged erection are also urgent warning signs. Do not drive yourself, and tell responders you have CML with a very high white blood cell count.
How do doctors check whether a high CML count is affecting my organs?
They assess your symptoms and physical function, measure blood oxygen, check kidney function, and review a blood smear. Depending on your findings, they may arrange an eye examination or hearing test to look for effects that are not obvious to you.
How is CML hyperleukocytosis treated if there is no leukostasis?
For chronic-phase CML without leukostasis, the usual priority is to start a targeted tyrosine kinase inhibitor promptly and monitor your blood counts. Your team may also use allopurinol and a prescribed hydration plan to reduce the risk of tumor lysis syndrome; do not change fluids or medicines without their instructions.
What treatments can lower the count quickly if leukostasis is suspected?
Doctors may use hydroxyurea as a temporary treatment to lower the white blood cell count quickly. In selected severe cases, leukapheresis, a procedure that removes excess white blood cells from the blood, may be considered while definitive CML treatment is planned.

Get notified when new evidence is published on Philadelphia-positive myelogenous leukemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    How I treat hyperleukocytosis in acute myeloid leukemia.

    Röllig C, Ehninger G

    Blood 2015; (125(21)):3246-52 doi:10.1182/blood-2014-10-551507.

    PMID: 25778528
  2. 2

    The management of hyperleukocytosis in 2017: Do we still need leukapheresis?

    Korkmaz S

    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis 2018; (57(1)):4-7 doi:10.1016/j.transci.2018.02.006.

    PMID: 29477941
  3. 3

    Complications at Diagnosis of Pediatric Chronic Myeloid Leukemia in Chronic Phase.

    Roy Moulik N, Athale U, Metzler M, et al.

    Pediatric blood & cancer 2025; (72(10)):e31946 doi:10.1002/pbc.31946.

    PMID: 40746223
  4. 4

    An Overview and Update of Chronic Myeloid Leukemia for Primary Care Physicians.

    Granatowicz A, Piatek CI, Moschiano E, et al.

    Korean journal of family medicine 2015; (36(5)):197-202 doi:10.4082/kjfm.2015.36.5.197.

    PMID: 26435808
  5. 5

    Another Emergent Cause of Headache.

    Wambolt SR, Garza J

    Cureus 2018; (10(5)):e2623 doi:10.7759/cureus.2623.

    PMID: 30027015
  6. 6

    Intracerebral hemorrhage as the first symptomatic manifestation of chronic myeloid leukemia (chronic phase): A case report and literature review.

    Ashraf M, Naseeruddin G, Zahra SG, et al.

    Surgical neurology international 2023; (14()):5 doi:10.25259/SNI_897_2022.

    PMID: 36751457
  7. 7

    [CHRONIC MYELOID LEUKEMIA IN A YOUNG MALE PRESENTING WITH BILATERAL CALF PAIN DUE TO LEUKOSTASIS].

    Rottenstreich M, Lavie M, Rottenstreich A

    Harefuah 2015; (154(5)):296-8, 340.

    PMID: 26168638
  8. 8

    A 27-YEAR-OLD FEMALE WITH MILD BLURRY VISION AND PROLONGED LIGHT ADJUSTMENT IN THE MORNING.

    Nanda T, Chin A, Rifkin L

    Retinal cases & brief reports 2023; (17(4S)):S11-S14 doi:10.1097/ICB.0000000000001336.

    PMID: 36007176
  9. 9

    Audiological profile for assessment of sensorineural hearing loss in treatment naïve chronic myeloid leukemia: impact of early TKI treatment on reversibility.

    Mamlekar H, Yadav S, Manogaran RS, et al.

    Annals of hematology 2026; (105(2)):65 doi:10.1007/s00277-026-06848-x.

    PMID: 41591557
  10. 10

    Physiological measurements corroborate symptomatic improvement after therapeutic leukapheresis in a pregnant woman with chronic myelogenous leukemia.

    Galera P, Haynes S, Sulmasy P, et al.

    Journal of clinical apheresis 2016; (31(4)):393-7 doi:10.1002/jca.21410.

    PMID: 26053950
  11. 11

    Intracranial Hemorrhage in a Pediatric Patient with Chronic Myeloid Leukemia in Chronic Phase: A Case Report.

    Takahashi N, Sano H, Mochizuki K, et al.

    Case reports in oncology 2021; (14(1)):525-530 doi:10.1159/000515011.

    PMID: 33976629
  12. 12

    Bilateral cochlear fibrosis complicating chronic myeloid leukemia: A CARE case report.

    Lahlou G, Daoudi H, Djian C, Mosnier I

    European annals of otorhinolaryngology, head and neck diseases 2025; (142(1)):42-45 doi:10.1016/j.anorl.2024.07.003.

    PMID: 39117480
  13. 13

    Intraoperative Collapse During First-Trimester Abortion: Hyperleukocytosis Crisis, Thrombotic Pulmonary Embolism, or Amniotic Fluid Embolism?

    Wen T, Zhang Y, Zhong Y, Song S

    International journal of women's health 2026; (18()):604225 doi:10.2147/IJWH.S604225.

    PMID: 42519500
  14. 14

    Priapism at Diagnosis of Pediatric Chronic Myeloid Leukemia: Data Derived from a Large Cohort of Children and Teenagers and a Narrative Review on Priapism Management.

    Suttorp M, Sembill S, Kalwak K, et al.

    Journal of clinical medicine 2023; (12(14)) doi:10.3390/jcm12144776.

    PMID: 37510891
  15. 15

    Hydroxyurea Bridging Before Frontline Tyrosine Kinase Inhibitor Therapy in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: A Critical Appraisal.

    Abdulgayoom M, Alshurafa A, Al-Mashdali AF, et al.

    Oncology 2026; 1-7 doi:10.1159/000553465.

    PMID: 42424252
  16. 16

    Chronic Myeloid Leukemia, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

    Deininger MW, Shah NP, Altman JK, et al.

    Journal of the National Comprehensive Cancer Network : JNCCN 2020; (18(10)):1385-1415.

    PMID: 33022644
  17. 17

    Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?

    Bewersdorf JP, Zeidan AM

    Cells 2020; (9(10)) doi:10.3390/cells9102310.

    PMID: 33080779
  18. 18

    Therapeutic Leukocytapheresis to relieve priapism due to leukostasis in CML patients: Our experience in a tertiary care centre.

    Sil S, Mohan AK, Negi G, et al.

    Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine 2024; (31(1)):36-40 doi:10.1016/j.tracli.2023.11.001.

    PMID: 37944664

This page is for informational purposes only and does not constitute medical advice. A very high white blood cell count in CML needs same-day guidance from your hematology team, and emergency symptoms require emergency services.